The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells

BACKGROUND: Phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a therapy target of cancer. We aimed to confirm the effect of dual PI3K/mTOR inhibitor NVP-BEZ235 on cell proliferation and apoptosis in Burkitt lymphoma (BL) cells. METHODS: Two human BL cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chuntuan, Xin, Pengliang, Xiao, Huifang, Zheng, Yan, Huang, Yuanling, Zhu, Xiongpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486138/
https://www.ncbi.nlm.nih.gov/pubmed/26130968
http://dx.doi.org/10.1186/s12935-015-0213-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486138/
https://www.ncbi.nlm.nih.gov/pubmed/26130968
http://dx.doi.org/10.1186/s12935-015-0213-1

Ejemplares similares